NCT02065648View on ClinicalTrials.gov

Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Vascular Disease
Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER

NCT02065648 - Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet | Biotech Hunter | Biotech Hunter